Implantable Neurostimulators Market Report 2026

Implantable Neurostimulators Market Overview

• Implantable Neurostimulators market size has reached to $6.76 billion in 2025 • Expected to grow to $11.44 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Neurological Disorders Prevalence Fuels Growth In Implantable Neurostimulators Market • Market Trend: Advanced Rechargeable Neurostimulator For Personalized Deep Brain Stimulation Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Neurostimulators Market?

Implantable neurostimulators are medical devices designed to deliver electrical impulses to specific parts of the nervous system to modulate or alter nerve activity. These devices are used to treat a variety of conditions, particularly chronic pain, neurological disorders, and other conditions where normal nerve function is impaired. The main purpose of an implantable neurostimulator is to regulate abnormal nerve signals or stimulate underactive nerves. The main product types of implantable neurostimulators are spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Spinal cord stimulators (SCS) are implantable devices designed to deliver electrical impulses to the spinal cord to block pain signals before they reach the brain. It is used for varying applications such as pain management, parkinson’s disease, urinary and fecal incontinence, epilepsy, gastroparesis, and others. The end users include hospitals, ambulatory surgical centers (ASCS), and others.

What Is The Implantable Neurostimulators Market Growth Forecast?

The implantable neurostimulators market size is expected to see rapid growth in the next few years. It will grow to $11.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to advancements in neurostimulation technology, expanding applications in parkinson’s disease and epilepsy, rising geriatric population with neurological conditions, increasing clinical evidence supporting neuromodulation, improved reimbursement and healthcare access. Major trends in the forecast period include growing adoption of implantable neurostimulators for chronic pain management, increasing preference for rechargeable neurostimulation devices, rising demand for minimally invasive neuromodulation therapies, expansion of indications beyond pain and movement disorders, enhanced focus on device longevity and patient comfort.

Global Implantable Neurostimulators Market Segmentation

1) By Product Type: Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Other Product Types 2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications 3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Uses Subsegments: 1) By Spinal Cord Stimulators: Conventional Spinal Cord Stimulators, Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, High-Frequency Spinal Cord Stimulators 2) By Deep Brain Stimulators: Single Lead Deep Brain Stimulators, Dual Lead Deep Brain Stimulators, Rechargeable Deep Brain Stimulators, Non-Rechargeable Deep Brain Stimulators 3) By Sacral Nerve Stimulators: Rechargeable Sacral Nerve Stimulators, Non-Rechargeable Sacral Nerve Stimulators, Implantable Pulse Generators For Sacral Nerve Stimulation 4) By Vagus Nerve Stimulators: Rechargeable Vagus Nerve Stimulators, Non-Rechargeable Vagus Nerve Stimulators, Vagus Nerve Stimulation Systems For Epilepsy Treatment 5) By Other Product Types: Transcranial Magnetic Stimulation (TMS) Devices, Peripheral Nerve Stimulators, Cochlear Implants

What Is The Driver Of The Implantable Neurostimulators Market?

The rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulators market going forward. Neurological disorders are conditions that affect the nervous system, including the brain and spinal cord, and influence functions like movement and cognition. The increase in neurological disorders is mainly due to the aging population, as longer lifespans make people more prone to conditions such as alzheimer's and parkinson's. Neurostimulators are implanted devices that deliver electrical impulses to control symptoms, including tremors and pain, in conditions such as epilepsy and Parkinson's. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, over 40% of the global population currently suffers from some neurological condition, and this burden is projected to nearly double by 2050. Therefore, the rising prevalence of neurological disorders drives the growth of the implantable neurostimulators industry.

Key Players In The Global Implantable Neurostimulators Market

Major companies operating in the implantable neurostimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova plc, Inspire Medical Systems Inc., Nevro Corporation, Axonics Inc., Cirtec Medical Systems LLC, SPR Therapeutics Inc., BlueWind Medical Ltd., NeuroPace Inc., Bioness Inc., ReShape Lifesciences Inc., Synapse Biomedical Inc., Autonomic Technologies Inc., Comphya SA, Mainstay Medical Holdings plc, Sigenics Inc., Nalu Medical Inc., Aleva Neurotherapeutics SA, Nuvectra Corporation

Global Implantable Neurostimulators Market Trends and Insights

Major companies in the implantable neurostimulators market are focusing on advanced innovations, including next-generation rechargeable systems that enhance existing DBS solutions and support more personalized treatment for movement-disorder patients. These new devices offer longer battery life, customizable therapy settings, and real-time brain-signal sensing in a compact, patient-friendly format. For example, in December 2024, Medtronic, a US-based medical technology company launched its FDA-approved Percept RC neurostimulator in India for conditions such as Parkinson’s disease, essential tremor, dystonia, and epilepsy. The Percept RC is the smallest and thinnest dual-channel rechargeable neurostimulator, equipped with BrainSense technology to record and interpret brain activity for optimized, individualized therapy adjustments. It features a long-lasting battery designed to exceed 15 years, fast recharging, full-body MRI compatibility under specific guidelines, and software-update readiness for future enhancements ultimately enabling more data-driven and adaptive deep brain stimulation therapy.

What Are Latest Mergers And Acquisitions In The Implantable Neurostimulators Market?

In September 2023, Amber Therapeutics Ltd. is a UK-based medical technology company, acquired Bioinduction Ltd. for an undisclosed amount. With this acquisition, Bioinduction will enhance its capabilities in developing innovative neuromodulation therapies, particularly for treating mixed urinary incontinence (MUI). Bioinduction Ltd. is a UK-based medical technology company that specializes in the manufacture of unique implantable neuromodulation devices.

Regional Outlook

North America was the largest region in the implantable neurostimulators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Implantable Neurostimulators Market?

The implantable neurostimulators market consists of sales of peripheral nerve stimulators, myostimulators, spinal cord stimulators, and brain stimulators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.